Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Spruce Biosciences (SPRB) Return on Sales (2023 - 2025)

Spruce Biosciences (SPRB) has disclosed Return on Sales for 3 consecutive years, with 68.69% as the latest value for Q3 2025.

  • Quarterly Return on Sales fell 5429.0% to 68.69% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 68.69% through Sep 2025, down 6314.0% year-over-year, with the annual reading at 10.8% for FY2024, 605.0% down from the prior year.
  • Return on Sales for Q3 2025 was 68.69% at Spruce Biosciences, down from 37.21% in the prior quarter.
  • The five-year high for Return on Sales was 3.43% in Q4 2023, with the low at 68.69% in Q3 2025.
  • Average Return on Sales over 3 years is 18.6%, with a median of 6.4% recorded in 2023.
  • The sharpest move saw Return on Sales soared 58bps in 2024, then tumbled -5429bps in 2025.
  • Over 3 years, Return on Sales stood at 3.43% in 2023, then tumbled by -885bps to 33.8% in 2024, then crashed by -103bps to 68.69% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 68.69%, 37.21%, and 19.13% for Q3 2025, Q2 2025, and Q1 2025 respectively.